Stay updated with breaking news from Adding tecentriq. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In patients with esophageal squamous cell carcinoma, the combination of Tecentriq, tiragolumab and chemotherapy improved survival outcomes, research found. ....
The addition of Tecentriq to Cabometyx did not improve the length of time patients lived without their disease getting worse for individuals with previously treated advanced kidney cancer, and came with additional side effects, too, recent research showed. ....